medigraphic.com
Instituto Nacional de Salud Pública

2008, Número 4

<< Anterior

salud publica mex 2008; 50 (4)


Los hantavirus causantes de la fiebre hemorrágica con síndrome renal y del síndrome pulmonar

Ramos C

Idioma: Español
Referencias bibliográficas: 56
Paginas: 334-339
Archivo PDF: 199.91 Kb.


RESUMEN

Este trabajo de revisión se enfoca en el análisis de la información básica sobre los hantavirus, agentes causales de dos enfermedades importantes en salud pública: la fiebre hemorrágica con síndrome renal (FHSR) y el síndrome pulmonar por hantavirus (SPH), dos zoonosis distribuidas en Asia/Europa y el continente americano, respectivamente. Los hantavirus se transmiten al hombre a través de la manipulación y contacto directos de roedores infectados o tejidos y secreciones (orina, heces y saliva). La FHSR y el SPH comparten algunas características clínicas, aunque las hemorragias y la afectación renal son propias de la FHSR,y los problemas respiratorios del SPH. Se aportan algunos datos sobre estudios realizados en México sobre hantavirus y se mencionan las condiciones ecológicas vinculadas con la distribución de los virus y sus reservorios naturales, así como algunas medidas para evitar o reducir el riesgo de infección.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Schmaljohn C, Hjelle B. Hantaviruses: a global disease problem. Emerg Infect Dis 1997;3:95-104.

  2. Nichol ST, Spiropoulou CF, Morzunov S, Rollin PE, Ksiazek TG, et al. Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness. Science 1993;262:914-917.

  3. Padula P, Martinez VP, Bellomo C, Maidana S, San Juan J, Tagliaferri P, et al. Pathogenic hantaviruses, Northeastern Argentina and Eastern Paraguay. Emerg Infect Dis 2007;13:1211-1214.

  4. Zeier M, Handeremann M, Bahr U, Rensch B, Muller S, Kehm, R, et al. New ecological aspects of hantavirus infection: a change of a paradigm and a challenge of prevention- a review. Virus Genes 2005;30:157-180.

  5. Elliot RM, Schmaljohn CS, Collett MS. Bunyaviridae genome structure and gene expression. In: Kolakofsky D, ed. Current topics in microbiology and immunology. Vienna: Springer-Verlag, 1991:91-141.

  6. Plyusnin A, Morzunov SP. Virus evolution and genetic diversity of hantaviruses and their hosts. Cur Top Microbiol Immunol 2001;256:47-75.

  7. Yates TL, Mills JN, Parmenter CA. The ecology and evolutionary history of an emergent disease: hantavirus pulmonary syndrome. Bioscience 2002;52:989-998.

  8. Murgue B, Domart Y, Coudrier D, Rollin PE, Darchis JP, Merrien D. First reported case of imported hantavirus pulmonary syndrome in Europe. Emerg Infect Dis 2002;8:106-107.

  9. Reynolds S, Galanis E, Krajden M, Morshed M, Bowering D, Abelson W, et al. Imported fatal hantavirus pulmonary syndrome. Emerg Infect Dis 2007;13:1424-1425.

  10. Centers for Disease Control and Prevention. Laboratory management of agents associated with hantavirus pulmonary syndrome: interim biosafety guidelines. Morb Mortal Wkly Rept 1994;7:1-2.

  11. Song JW, Back LJ, Nagle JW, Schlitter D, Yanagihara R. Genetic and phylogenetic analyses of hantaviral sequences amplified from archival tissues of deer mice (Peromyscus maniculatus nubiterrae) captured in the eastern United States. Arch Virol 1996;141:959-967.

  12. Botten J, Mirowsky K, Kusewitt D, Bharadwaj M, Yee J, Ricci R, et al. Experimental infection model for Sin Nombre hantavirus in the deer mouse (Peromyscus maniculatus). Proc Natl Acad Sci USA 2000;97:10578-10583.

  13. Centers for Disease Control and Prevention. [Consultado en mayo de 2006]. Disponible en: http://www.cdc.gov/hantavirus.

  14. Maes P, Clement J, Gavrilovskaya I, Van Ranst M. Hantaviruses: immunology, treatment, and prevention. Review. Viral Immunol 2004;17:481-497.

  15. Moreli ML, Sousa RL, Figueiredo LT. Detection of Brazilian hantavirus by reverse transcription polymerase chain reaction amplification of N gene in patients with hantavirus cardiopulmonary syndrome. Mem Inst Oswaldo Cruz 2004;99:633-638.

  16. Hantavirus in the Americas: guidelines for diagnosis, treatment, and control. Cuaderno Técnico No. 47. Washington, DC: Panamerican Health Organization, 1999.

  17. Hjelle B, Anderson B, Torres-Martinez N, Song W, Gannon WL, Yates TL. Prevalence and geographic genetic variation of hantaviruses of New World harvest mice (Reitrodontomys): identification of a divergent genotype from a Costa Rican Reithrodontomys mexicanus. Virology 1995;207:452-459.

  18. Chen LB, Yang WS. Abnormalities of T cell immunoregulation in hemorrhagic fever with renal syndrome. J Infect Dis 1990;161:1016-1019.

  19. Yanigahara R, Silverman DJ. Experimental infection of human vascular endothelial cells by pathogenic and nonpathogenic hantaviruses. Arch Virol 1990;111:281-286.

  20. Peters CJ, Simpson GL, Levy H. Spectrum of hantavirus infection: hemorrhagic fever with renal syndrome and hantavirus pulmonary syndrome. Annu Rev Med 1999;50:531-545.

  21. Hjelle B, Jenison S, Torrez-Martinez N. Rapid and specific detection of Sin Nombre virus antibodies in patients with hantavirus pulmonary syndrome by a strip immunoblot assay suitable for field diagnosis. J Clin Microbiol 1997;35:600-608.

  22. Centers for Disease Control and Prevention. All about hantavirus. Atlanta, Ga: National Center for Infectious Diseases. Special Pathogens Branch, 2006.

  23. Huggins JW, Hsiang CM, Cosgriff TM. Prospective, double-blind, concurrent, placebo controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome. J Infect Dis 1991;164:1119-1127.

  24. Cho HW, Howard CR. Antibody responses in humans to an inactivated hantavirus vaccine (Hantavax). Vaccine 1999;17:2569-2575.

  25. Park K, Kim CS, Moon KT. Protective effectiveness of hantavirus vaccine. Emerg Infect Dis 2004;10:2218-2220.

  26. Cho HW, Howard CR, Lee HW. Review of an inactivated vaccine against hantaviruses. Intervirology 2002;45:328-333.

  27. Childs JE, Ksiazek TG, Spiropoulou CF. Serologic and genetic identification of Peromyscus maniculatus as the primary rodent reservoir for a new hantavirus in the southwestern United States. J Infect Dis 1994;169:1271-1280.

  28. Duchin JS, Koster F, Peters CJ. Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. N Engl J Med 1994;330:949-955.

  29. Nolte KB, Feddersen RM, Foucar K. Hantavirus pulmonary syndrome in the United States: a pathological description of a disease caused by a new agent. Hum Pathol 1995;26:110-120.

  30. Monroe MC, Morzunov SP, Johnson AM. Genetic diversity and distribution of Peromyscus-borne hantaviruses in North America. Emerg Infect Dis 1999;5:75-86.

  31. Rhodes LV, Huang C, Sanchez AJ, Nichol ST, Zaki SR, Ksiazek TG, et al. Hantavirus pulmonary syndrome associated with Monongahela virus, Pennsylvania. Emerg Infect Dis 2000;6:616-621.

  32. Mantooth SJ, Milazzo ML, Bradley RD, Hice CL, Ceballos G, Tesh RB, et al. Geographical distribution of rodent-associated hantaviruses in Texas. J Vector Ecol 2001;26:7-14.

  33. Sinclair JR, Carroll DS, Montgomery JM, Pavlin M, McCombs K, Mills JN, et al. Two cases of hantavirus pulmonary syndrome in Randolph County, West Virginia: a coincidence of time and place? Am J Trop Med Hyg 2007;76:438-442.

  34. Centers for Disease Control and Prevention. Case Information: hantavirus pulmonary syndrome case count and descriptive statistics. Available at http://www.cdc.gov/ncidod/diseases/hanta/noframes/caseinfo.htm. [Access on: february 27, 2006.]

  35. Gavrilovskaya IN, Shapley M, Shaw R, Ginsberg MH, Mackow ER. �3 integrins mediate the cellular entry of hantaviruses that cause respiratory failure. Proc Natl Acad Sci USA 1998;95:7074-7079.

  36. Padula PJ, Edelstein A, Miguel SDL, Lopez NM, Rossi CM, Rabinovich RD. Hantavirus pulmonary syndrome outbreak in Argentina: molecular evidence for person-to- person transmission of Andes virus. Virology 1998;241:323-330.

  37. Elgh F, Lundkvist A, Alexeyev OA. Serological diagnosis of hantavirus infections by an enzyme-linked immunosorbent assay based on detection of immunoglobulin G and M responses to recombinant nucleocapsid proteins of five viral serotypes. J Clin Microbiol 1997;35:1122-1130.

  38. Johnson AM, Bowen MD, Ksiazek TG, Williams RJ, Bryan RT, Mills JN, et al. Laguna Negra virus associated with HPS in western Paraguay and Bolivia. Virology 1997;238:115-127.

  39. Lopez N, Padula P, Rossi C, Miguel S, Edelstein A, Ramirez E, et al. Genetic characterization and phylogeny of Andes virus and variants from Argentina and Chile. Virus Res 1997;50:77-84.

  40. Levis S, Morzunov S, Rowe JE, Enria DA, Pini N, Calderon G. Genetic diversity and epidemiology of hantavirus in Argentina. J Infect Dis 1998;177:529-538.

  41. Chu YK, Owen RD, Gonzalez LM, Jonsson CB. The complex ecology of hantavirus in Paraguay. Am J Trop Med Hyg 2003;69:263-268.

  42. Rosa EST, Mills NJ, Padula PJ. Newly recognized hantavirus associated with hantavirus pulmonary syndrome in northern Brazil: partial genetic characterization of viruses and serologic implication of likely reservoirs. Vector Borne Zoonotic Dis 2005;5:11-19.

  43. Carroll DS, Mills JN, Montgomery JM, Bausch DG, Blair PJ, Burans JP, et al. Hantavirus pulmonary syndrome in Central Bolivia: relationships between reservoir hosts, habitats, and viral genotypes. Am J Trop Med Hyg 2005;72:42-46.

  44. Raboni SM, Rubio G, De Borba I, Zeferino A, Skraba I, Goldenberg S. Clinical survey of hantavirus in southern Brazil and the development of specific molecular diagnosis tools. Am J Trop Med Hyg 2005;72:800-804.

  45. Mills JN, Yates TL, Childs JE, Parmenter RR, Ksiazek TG, Rollin PE, et al. Guidelines for working with rodents potentially infected with hantavirus. J Mammology 1995;76:716-722.

  46. Mills JN, Childs JE, Ksiazek TG, Peters CJ, Velleca WN. Methods for trapping and sampling small mammals for virologic testing. US Department of Health & Human Services. Public Helath Service. Atlanta, Ga: Centers for Disease Control and Prevention, 1995.

  47. Kelt DA, Van Vuren DH, Hafner MS, Danielson BJ, Kelly MJ. Threat of hantavirus pulmonary syndrome to field biologists working with small mammals. Emerg Infect Dis 2007;13:1285-1287.

  48. Sánchez-Cordero V, Peterson AT, Martínez-Meyer E, Flores R. Distribución de roedores reservorios del virus causante del síndrome pulmonar por hantavirus y regiones de posible riesgo de México. Acta Zool Mex 2005;21:79-91.

  49. Vado-Solís I, Pérez-Osorio C, Lara-Lara H, Ruiz-Piña HA, Cárdenas- Marrufo M, Milazzo ML, et al. Evidencia serológica de infección por hantavirus en población humana del estado de Yucatán, México. Rev Biomed 2003;14:221-225.

  50. Suzan G, Ceballos G, Mills J, Ksiazek TG, Yates T. Serologic evidence of hantavirus infection in Sigmodontine rodents in Mexico. J Wild Dis 2001;37:391-393.

  51. Castro-Arellano I, Suzan G, Flores-Leon R, Morales-Jimenez R, Lacher TE. First report of hantavirus occurrence in the nimble-footed mouse Peromyscus levipes, in northern Mexico. Peromyscus Newsletter 2007;42:36.

  52. Chu YK, Owen R, Sanchez-Hernandez C, Romero-Almaraz ML, Jonsson CB. Genetic characterization and phylogeny of a hantavirus from Western México. Virus Res 2007;131:180-188.

  53. Milazzo ML, Cajimat MN, Hanson JD, Bradley RD, Quintana M, Sherman C, et al. Catacamas virus, a hantaviral species naturally associated with Oryzomys couesi in Honduras. Am J Trop Med Hyg 2006;75:1003-1010.

  54. Dragoo JW, Lackey JA, Moore KE, Lessa EP, Cook JA, Yates TL. Phylogeography of the deer mouse (Peromyscus maniculatus) provides a predictive framework for research on hantavirus. J Gen Virol 2006;87:1997-2003.

  55. Armstrong L, Zaki S, Goldoft M, Todd R, Khan A, Khabbaz R. Hantavirus pulmonary syndrome associated with entering or cleaning rarely used rodent-infested structures. J Infect Dis 1995;172:1166.

  56. Kilpatrick ED, Terajima M, Koster Ft, Catalina MD, Cruz J, Ennis FA. Role of specific CD8+ T cells in the severity of a fulminant zoonotic viral hemorrhagic fever, hantavirus pulmonary syndrome. J Immunol 2004;172:3297-3304.




2020     |     www.medigraphic.com